Federal Cannabis Rescheduling Moves Through Formal DEA Hearing
The DEA scheduled formal proceedings from June 29 through July 15 concerning the broader proposal to move marijuana from Schedule I to Schedule III. The proceeding is part of the federal rulemaking process and does not itself legalize adult-use cannabis nationwide.
Federal cannabis policy entered another major phase in 2026 as the Drug Enforcement Administration scheduled formal hearing proceedings concerning the proposed rescheduling of marijuana.
The hearing schedule began June 29 and extended through July 15. It addressed the broader proposal to move marijuana from Schedule I to Schedule III under the federal Controlled Substances Act.
The hearing followed an April Justice Department action involving FDA-approved marijuana products and qualifying state-regulated medical marijuana products. The broader legal status of marijuana remained subject to the federal rulemaking process.
For consumers and businesses, rescheduling and legalization are not interchangeable. A scheduling change may affect research, medical policy, taxation and regulation, but it does not automatically create nationwide legal adult-use sales.
The Cannabis League will continue following official DEA and Justice Department actions as the process develops.
Sources & Verification
- Drug Enforcement AdministrationDEA Hearing on Proposed Marijuana Rescheduling Begins June 29Government announcementPrimary sourcePublished June 25, 2026Accessed July 18, 2026
- U.S. Department of JusticeJustice Department Action Concerning Marijuana Products and Rescheduling ProceedingsGovernment announcementPrimary sourcePublished April 24, 2026Accessed July 18, 2026
